Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company’s mesh nebulizer technology has been cleared by the FDA as substantially equivalent to predicate devices. It supports both small molecule and biologic formulations—including advanced modalities like LNP-mRNA—and features app-based digital solutions to improve patient adherence and optimize dosing. Products are exported to over 40 countries with established partnerships in the biopharma sector. Clinical results focus on device performance equivalence and enhanced user experience rather than therapeutic efficacy per se.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Future Medical Technology.